Biofrontera Inc. (BFRI) — Financial statements
Income statement, balance sheet, and cash flow for Biofrontera Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 42↑11.8% | 37↑9.5% | 34↑18.8% | 29↑19.0% | 24 | |
| Cost of Revenue | 9↓52.2% | 19↑6.7% | 17↑14.9% | 15↑19.2% | 13 | |
| Gross Profit | 33↑75.5% | 19↑12.4% | 17↑23.3% | 13↑18.8% | 11 | |
| Operating Expenses | ||||||
| R&D Expenses | 4↑78.0% | 2↑2613.0% | 0.08 | 0.00 | 0.00 | |
| General & Administrative Expenses | 0.00 | 0.00↓100.0% | 38↑5.1% | 36↓3.6% | 37 | |
| Selling & Marketing Expenses | 0.00 | 0.00↓100.0% | 1 | 0.00 | 0.00 | |
| SG&A Expenses | 38↑12.7% | 34↓13.5% | 39↑9.1% | 36↓3.6% | 37 | |
| Other Expenses | 0.10 | 0.00↓100.0% | 0.10↑102.6% | -4↓484.6% | -0.65 | |
| Operating Expenses | 42↑16.8% | 36↓8.6% | 39↑22.6% | 32↓12.3% | 37 | |
| Total Costs & Expenses | 51↓6.7% | 55↓3.9% | 57↑20.1% | 47↓4.2% | 49 | |
| Operating Results | ||||||
| Operating Income | -9↑46.8% | -17↑24.1% | -23↓22.0% | -19↑26.3% | -25 | |
| Depreciation & Amortization | 0.87↓24.5% | 1↑8.0% | 1↓9.2% | 1↑117.0% | 0.54 | |
| EBITDA | -8↑42.7% | -14↑21.7% | -18↓2075.7% | 0.93↑102.5% | -37 | |
| EBIT | -9↑41.5% | -16↑19.9% | -20↓8100.4% | -0.24↑99.4% | -37 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.45↑78.2% | -2↓343.6% | -0.47↓140.0% | -0.20↑43.3% | -0.34 | |
| Interest Income | 0.00↓100.0% | 0.03↓77.3% | 0.13↓24.6% | 0.18↑993.8% | 0.02 | |
| Interest Expense | 0.45↓78.5% | 2↑251.0% | 0.60↑62.2% | 0.37↑2.8% | 0.36 | |
| Non-Operating Income | 0.00↑100.0% | -2↑50.0% | -3↑82.8% | -18↓251.6% | 12 | |
| Other Income / Expenses | -1↓158.6% | -0.53↓120.6% | 3↓85.8% | 18↑244.3% | -12 | |
| Income Before Tax | -11↑40.7% | -18↑11.8% | -20↓3208.7% | -0.61↑98.4% | -38 | |
| Income Tax Expense | 0.03↑13.6% | 0.02↑57.1% | 0.01↓56.3% | 0.03↓42.9% | 0.06 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -11↑40.7% | -18↑11.8% | -20↓3045.5% | -0.64↑98.3% | -38 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -11↑40.7% | -18↑11.8% | -20↓3045.5% | -0.64↑98.3% | -38 | |
| Bottom-Line Net Income | -11↑40.7% | -18↑11.8% | -20↓3045.5% | -0.64↑98.3% | -38 | |
| EPS (Basic) | -1.04↑67.7% | -3.22↑75.3% | -13.02↓2034.4% | -0.61↑98.6% | -44.10 | |
| EPS (Diluted) | -0.90↑72.0% | -3.22↑75.3% | -13.02↓2034.4% | -0.61↑98.6% | -44.10 | |
| Weighted Average Shares | 10↑84.4% | 6↑256.7% | 2↑46.3% | 1↑23.6% | 0.86 | |
| Weighted Average Diluted Shares | 12↑111.2% | 6↑256.7% | 2↑46.3% | 1↑23.6% | 0.86 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.